7 results match your criteria: "Hyogo Prefectural Kobe Children hospital[Affiliation]"
Blood Adv
March 2024
Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Ann Clin Microbiol Antimicrob
November 2023
Division of Infectious Disease, Department of Pediatrics, Hyogo Prefectural Kobe Children hospital, Kobe City, 6500047, Hyogo, Japan.
Background: Tsukamurella spp. are obligate aerobic, gram-positive, non-motile, and slightly acid-fast bacilli belonging to the Actinomycetes family. They share many characteristics with Nocardia, Rhodococcus, Gordonia, and the rapidly growing Mycobacterium species.
View Article and Find Full Text PDFPediatr Int
January 2022
Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
Background: Most antimicrobials are prescribed to outpatients, making outpatient antibiotic prescription an important target for antibiotic stewardship. A national antimicrobial resistance (AMR) action plan was developed in 2016 by the Japanese government with various antimicrobials steawardship activities for pediatric outpatients. We aimed to evaluate changes in antibiotic use pre- and post-implementation of the AMR action plan.
View Article and Find Full Text PDFEur J Clin Microbiol Infect Dis
April 2022
Institute of Infection and Immunity, St George's University of London, London, UK.
We aimed to define the burden and clinical features of invasive group B streptococcus (GBS) disease in infants younger than 1 year in Japan, to explore transmission route of late-onset disease (LOD), and to identify risk factors associated with recurrent GBS disease. We conducted a retrospective, questionnaire-based nationwide surveillance study between 2016 and 2020. A total of 875 GBS cases were identified, including 186 early-onset disease, 628 LOD, and 61 ultra-late-onset disease.
View Article and Find Full Text PDFInfect Control Hosp Epidemiol
September 2020
National Center for Child Health and Development, Tokyo, Japan.
Objective: To determine whether carbapenem consumption and Pseudomonas aeruginosa resistance rates can be used as benchmarks to compare and improve antimicrobial stewardship programs across multiple pediatric hospitals.
Design: A prospective study.
Setting And Participants: Healthcare institutions in Japan with >100 pediatric beds.
Jpn J Infect Dis
May 2019
Division of Infectious Diseases, Department of Medical Subspecialties, Research Institute, National Center for Child Health and Development.
In Japan, 92.6% of antibiotics consumed are oral agents; most of these are for outpatients. A significant proportion is known to be dispensed for children; however, the specific pattern of antibiotic prescription in accordance with clinical specialty is still unclear.
View Article and Find Full Text PDFJ Infect Chemother
January 2019
Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan; Department of Microbiology, Immunology, and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, USA. Electronic address:
Background: Antimicrobial resistance (AMR) is a major multinational public health concern. The Japanese government set goals in its AMR action plan to reduce use of oral cephalosporins, macrolides, and quinolones by half between 2013 and 2020. We aimed to evaluate antimicrobial use in children in Japan by observing prescription patterns as an interim assessment of the national AMR action plan.
View Article and Find Full Text PDF